This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. OCGN slid 2.79% to $2.44 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.30% to 3,900.11 and Dow Jones Industrial Average DJIA falling 0.20% to 31,438.26. This was the stock's second consecutive day of losses. Ocugen Inc. closed $15.21 short of its 52-week high ($17.65), which the company achieved on November 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Adverum Biotechnologies Inc. ADVM remained unchanged, Ocular Therapeutix Inc. OCUL rose 3.01% to $4.11, and Kodiak Sciences Inc. KOD fell 6.97% to $8.41. Trading volume (4.9 M) remained 2.3 million below its 50-day average volume of 7.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 27, 2022.
(END) Dow Jones Newswires
June 27, 2022 17:12 ET (21:12 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.